A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich
Article Abstract:
Normal body temperature should be considered to be 98.2 degrees F and 99.9 degrees F should be the upper limit of normal body temperature. A study of 148 healthy adults ages 18 through 40 showed that normal temperatures differed from results of studies published in 1868. These earlier results were from 1 million axillary temperature readings. Current research found that 98.9 degrees F is the upper limit of normal temperatures in the early morning and 99.9 degrees F is the upper limit of normal in the afternoon. Black people tended to have higher temperatures than white people in the current study. Wunderlich's work, published in 1868, measured axillary temperature (under the armpit), not oral temperature. The original work did not consider the affect of age, race or great individual differences, which make determining the average more difficult.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Medicine and public health: pursuing a common destiny
Article Abstract:
The national office of the Medicine/Public Health Initiative has been established at The University of Texas at Houston. The initiative grew out of a lecture on the divergence of medicine and public health to a joint audience of students and faculty in medicine and public health. From this came a national congress in Chicago in March, 1996 that sought to bring both disciplines together. In the past, medicine focused on the individual patient while public health focused on the health of communities. The rise of managed care has fostered cooperation between medicine and public health.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Safety and immunogenicity of a recombinant mutivalent group A streptococcal vaccine in healthy adults
Article Abstract:
The safety and immunogenity of ascending doses of a recombinant fusion peptide group A streptococcal vaccine containing N-terminal M protein fragments from sereotypes 1,3,5,6,19 and 24 in healthy volunteers are evaluated. The result provide the first evidence in humans that a hybrid fusion protein is a feasible strategy for evoking type-specific opsonic antibodies against multiple serotypes of group A.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A national health program: abyss at the end of the tunnel - the position of physicians who care. The Health Security Partnership: a federal-state universal insurance and cost-containment program
- Abstracts: Essential tremor: it's not simply another part of growing older. Glaucoma medication may diminish tremor
- Abstracts: Medicaid: the role of the states. The politics of Medicare
- Abstracts: Technical guidance on HIV counseling. Update: HIV-2 infection among blood and plasma donors - United States, June 1992-June 1995
- Abstracts: Recovery, resterilization, and donation of unused surgical supplies. Case-by-case assessment of recoverable materials for overseas donation from 1318 surgical procedures